Indeed, a study reported that ROS generated by NADPH oxidase was enormously elevated in circulating lymphocytes and monocytes even in the early stages of CKD (Fortuno et al., 2005; Duni et al., 2017). This evidence concerns the gene FMO5 and chronic kidney disease.